[{"address1": "3300 Nacogdoches Road", "address2": "Suite 216", "city": "San Antonio", "state": "TX", "zip": "78217", "country": "United States", "phone": "210 698 5334", "website": "https://www.bioaffinitytech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Girgenti", "age": 78, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 115430, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Zannes J.D.", "age": 68, "title": "Founder, President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 327157, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Xavier T. Reveles M.S.", "age": 54, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Bauta Ph.D.", "title": "Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Zannes J.D.", "age": 71, "title": "Executive VP, Secretary & General Counsel", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie Anne Overton", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallas J. Coleman", "title": "Vice President of sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gordon  Downie M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2392, "open": 0.2344, "dayLow": 0.2335, "dayHigh": 0.24, "regularMarketPreviousClose": 0.2392, "regularMarketOpen": 0.2344, "regularMarketDayLow": 0.2335, "regularMarketDayHigh": 0.24, "payoutRatio": 0.0, "beta": 2.543, "forwardPE": -0.3983333, "volume": 86871, "regularMarketVolume": 86871, "averageVolume": 4467138, "averageVolume10days": 263300, "averageDailyVolume10Day": 263300, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 6809683, "fiftyTwoWeekLow": 0.164, "fiftyTwoWeekHigh": 2.259, "priceToSalesTrailing12Months": 0.88655525, "fiftyDayAverage": 0.29066, "twoHundredDayAverage": 0.536845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6603537, "profitMargins": -1.52179, "floatShares": 22864781, "sharesOutstanding": 28468600, "sharesShort": 985929, "sharesShortPriorMonth": 1273824, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0346, "heldPercentInsiders": 0.18887, "heldPercentInstitutions": 0.01461, "shortRatio": 0.65, "shortPercentOfFloat": 0.0394, "impliedSharesOutstanding": 28492400, "bookValue": -0.076, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11688941, "trailingEps": -0.57, "forwardEps": -0.6, "enterpriseToRevenue": 0.86, "enterpriseToEbitda": -0.696, "52WeekChange": -0.8280575, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 0.239, "recommendationKey": "none", "totalCash": 802835, "totalCashPerShare": 0.028, "ebitda": -9490369, "totalDebt": 669997, "quickRatio": 0.473, "currentRatio": 0.645, "totalRevenue": 7681059, "revenuePerShare": 0.455, "returnOnAssets": -1.10268, "returnOnEquity": -18.0245, "grossProfits": 2294273, "freeCashflow": -3465642, "operatingCashflow": -7675376, "revenueGrowth": -0.471, "grossMargins": 0.29869, "ebitdaMargins": -1.23555, "operatingMargins": -1.9815601, "financialCurrency": "USD", "symbol": "BIAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1757116778, "regularMarketTime": 1757102401, "exchange": "NCM", "messageBoardId": "finmb_423045573", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "bioAffinity Technologies, Inc.", "longName": "bioAffinity Technologies, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1662039000000, "postMarketChangePercent": 2.9288764, "postMarketPrice": 0.246, "postMarketChange": 0.007000014, "regularMarketChange": -0.000200003, "regularMarketDayRange": "0.2335 - 0.24", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4467138, "fiftyTwoWeekLowChange": 0.07499999, "fiftyTwoWeekLowChangePercent": 0.457317, "fiftyTwoWeekRange": "0.164 - 2.259", "fiftyTwoWeekHighChange": -2.02, "fiftyTwoWeekHighChangePercent": -0.8942009, "fiftyTwoWeekChangePercent": -82.805756, "earningsTimestampStart": 1755174600, "earningsTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "marketState": "CLOSED", "corporateActions": [], "epsTrailingTwelveMonths": -0.57, "epsForward": -0.6, "epsCurrentYear": -0.48, "priceEpsCurrentYear": -0.49791667, "fiftyDayAverageChange": -0.05166, "fiftyDayAverageChangePercent": -0.17773344, "twoHundredDayAverageChange": -0.29784504, "twoHundredDayAverageChangePercent": -0.55480635, "priceToBook": -3.1447368, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-08-25", "cryptoTradeable": false, "regularMarketChangePercent": -0.0836135, "regularMarketPrice": 0.239, "displayName": "bioAffinity", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]